Global Diagnostic Neuroimaging Markets and Emerging Applications, Forecast to 2022

Headways in Neuroimaging Continues to Play a Promising Care Pathway in Diagnosis and Treatment of Major Neurological Disorders

The scope of this research study covers the diagnostic applications of advanced imaging in neurological and neurodegenerative disorders. The geographical market covered is North America (US), Europe, and Asia-Pacific (APAC).

Key Features

This research service provides the following metrics:

• A quantification of the size of procedure volumes for select neurology disorders (Alzheimer’s disease, Epilepsy, Parkinson’s disease, Multiple Sclerosis, Stroke and Brain Tumor) for the above-mentioned markets from 2017 to 2022
• Market forecasts presenting the incidence and prevalence population for neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis
• Insight into brain imaging and neuroimaging technologies, insights into technology trends, future diagnostic and therapeutic perspectives, and competitive landscape
• Diagnostic imaging procedure volumes and service market revenue estimates for select neurology disorders (Alzheimer’s disease, epilepsy, Parkinson’s disease, multiple sclerosis, Stroke and Brain Tumor) for the base year 2017
• Key insights on recent advancements in neuroinformatics initiatives and novel platforms shaping the future, including Artificial Intelligence (AI) applications in neuroimaging focusing on new advancements and future developments.
• Current key products and solutions offerings in neuroimaging software applications
• Growth opportunities and companies to action section that enlists the key roles that can be taken up by companies for growth along with an illustrative list of key company profiles including GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, Ricoh, Hitachi, and Shimadzu

Key Issues Addressed

• What are some of the major neurological disorders burdening the society today and what potential treatments and breakthroughs can be expected in the near future?
• What major imaging modalities make up the neuroimaging market and what is the proportion of imaging techniques used for diagnosis and treatment of key neurological disorders?
• What is the estimated neuroimaging procedure volume and service market revenue of imaging technologies for different geographies like North America, Europe, and APAC?
• Are the vendors in the space ready to go it alone or do they need partnerships to take their businesses to the next level? Are there any novel start-ups and/or products?
• How is the role of neuroimaging technologies and solutions in the diagnosis and treatment pathways for neurological disorders changing? What are the current gold standards? How will future imaging technologies play a role to overcome the neurological disorders challenge, especially neurodegenrative disorders like Alzheimer's and Parkinson’s?
• Are the products and services offered today meeting customer needs or is additional development needed e.g., in neuroinformatics? Have Artificial Intelligence (AI) and machine learning started making an impact in neuroimaging? Are there any growth opportunities?